Citations

Citations to this article as recorded by  

• Correspondence to editorial 1 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
  Haiyu Wang, Jinjun Chen
  Clinical and Molecular Hepatology.2026; 32(1): e58.     CrossRef

Citations

Citations to this article as recorded by  

• Systemic inflammatory indexes as predictors of 18-month mortality among cirrhotic patients receiving transjugular intrahepatic portosystemic shunt
  Jie Cheng, Xiaobing Wang, Lihua Zhou, Xiaojia Chen, Nuer Tang, Feng Zhou, Feng Ding, Yuan Yang, Jun Lin, Liping Chen
  Annals of Medicine.2025;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• TIPS insertion and systemic inflammation: Is it ever too late to lower portal pressure? Correspondence to editorial on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with deco
  Anja Tiede, Benjamin Maasoumy
  Clinical and Molecular Hepatology.2025; 31(2): e176.     CrossRef
• Decreasing systemic inflammation after TIPS: Still hope for the liver: Reply to correspondence on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrh
  Georg Semmler, Lorenz Balcar, Mattias Mandorfer
  Clinical and Molecular Hepatology.2025; 31(2): e224.     CrossRef
• Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute Decompensation
  Lucie Simonis, Lorenz Balcar, Anna Schedlbauer, Marta Tonon, Nikolaj Torp, Valeria Santori, Katharina Stopfer, Jan Embacher, Christian Sebesta, Leonie Hafner, Benedikt Silvester Hofer, Nina Dominik, Georg Kramer, Paul Thöne, Michael Trauner, Aleksander Kr
  Alimentary Pharmacology & Therapeutics.2025; 62(11-12): 1202.     CrossRef
• Systemic inflammatory indexes as predictors of 18-month mortality among cirrhotic patients receiving transjugular intrahepatic portosystemic shunt
  Jie Cheng, Xiaobing Wang, Lihua Zhou, Xiaojia Chen, Nuer Tang, Feng Zhou, Feng Ding, Yuan Yang, Jun Lin, Liping Chen
  Annals of Medicine.2025;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Early portal hypertension in metabolic dysfunction-associated steatotic liver disease: a concise review
  Iván López-Méndez, Eva Juárez-Hernández, Juan Pablo Soriano-Márquez, Misael Uribe, Graciela Castro-Narro
  Expert Review of Gastroenterology & Hepatology.2025; 19(7): 755.     CrossRef
• Combination of modified albumin-bilirubin grade and platelet count to predict high-risk varices in patients with hepatocellular carcinoma
  Prooksa Ananchuensook, Kingkomon Piyawannasuth, Sirinporn Suksawatamnuay, Panarat Thaimai, Nipaporn Siripon, Supachaya Sriphoosanaphan, Kessarin Thanapirom, Piyawat Komolmit, Wenyu Lin
  PLOS One.2025; 20(7): e0327967.     CrossRef
• Noninvasive model based on liver and spleen stiffness for predicting clinical decompensation in patients with cirrhosis
  Long-Bao Yang, Xin Gao, Meng Xu, Yong Li, Lei Dong, Xin-Di Huang, Xiao She, Dan-Yang Zhang, Qian-Wen Zhang, Chen-Yu Liu, Shu-Ting Fan, Yan Wang
  World Journal of Gastroenterology.2025;[Epub]     CrossRef
• Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension
  Georg Semmler, Lukas Hartl, Yuly Paulin Mendoza, Benedikt Simbrunner, Mathias Jachs, Lorenz Balcar, Michael Schwarz, Benedikt Silvester Hofer, Laurenz Fritz, Anna Schedlbauer, Katharina Stopfer, Daniela Neumayer, Jurij Maurer, Robin Szymanski, Elias Lauri
  Hepatology.2024; 80(4): 887.     CrossRef
• Portal hypertension and its prognostic implications in patients with Wilson's disease
  Lukas Burghart, Peter Ferenci, Oleksandr Petrenko, Mattias Mandorfer, Michael Schwarz, Michael Gschwantler, Michael Trauner, Thomas Reiberger, Albert Friedrich Stättermayer
  Alimentary Pharmacology & Therapeutics.2024; 60(2): 257.     CrossRef
• Folic acid supplementation is associated with a decreased mortality and reduced hospital readmission in patients with decompensated alcohol-related liver cirrhosis
  Laura Buttler, Anja Tiede, Marie Griemsmann, Hannah Rieland, Jim Mauz, Julia Kahlhöfer, Heiner Wedemeyer, Markus Cornberg, Tammo L. Tergast, Benjamin Maasoumy, Katharina L. Hupa-Breier
  Clinical Nutrition.2024; 43(8): 1719.     CrossRef
• Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
  Yu Jun Wong, Sanchit Sharma, Giulia Tosetti, Xiaolong Qi, Massimo Primignani
  Clinical and Molecular Hepatology.2023; 29(1): 188.     CrossRef
• Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”
  Jeong-Ju Yoo, Sang Gyune Kim
  Clinical and Molecular Hepatology.2023; 29(2): 513.     CrossRef
• Validation of non‐invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII
  Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Seung Woon Paik, Dong Hyun Sinn
  Liver International.2023; 43(9): 1966.     CrossRef
• Lymphatic drainage dysfunction is related to clinically significant portal hypertension
  Ruixue Ma, Yasuko Iwakiri
  Hepatology International.2023; 17(6): 1327.     CrossRef